Literature DB >> 33927491

Comparative Analysis of the Anesthetic Efficacy of 0.5% Ropivacaine Versus 2% Lignocaine Hydrochloride with Adrenaline (1:80,000) for Inferior Alveolar Nerve Block in Surgical Removal of Impacted Mandibular Third Molars.

Ram Goyal1, Parveen Sharma1, Rishi Bali1.   

Abstract

OBJECTIVE: To compare the onset, duration and depth of anesthesia, postoperative pain, duration of analgesia and adverse reaction between 0.5% ropivacaine and 2% Lignocaine hydrochloride with adrenaline (1:80,000) in 40 patients having bilaterally impacted mandibular third molars. PATIENTS AND METHODS: A prospective, randomized, single blind study was carried out among 40 patients requiring surgical removal of bilaterally impacted mandibular third molars having similar "difficulty index." The onset of action, duration and depth of anesthesia, duration of analgesia, postoperative pain and adverse reactions of 0.5% ropivacaine and 2% lignocaine hydrochloride with 1:80,000 adrenaline were evaluated. All patients were infiltrated intradermally with 0.5 ml of 0.5% ropivacaine as test dose to rule out any allergic reaction. The surgical extractions of the impacted third molars were done using the standard surgical procedure.
RESULTS: 0.5% Ropivacaine had higher depth of anesthesia, longer duration of action and postoperative analgesic effect than 2% Lignocaine hydrochloride with 1:80,000 adrenaline with no adverse effects.
CONCLUSION: 0.5% ropivacaine is safe, efficacious, clinically acceptable and equally potent local anesthetic agent when compared to 2% lignocaine with 1:80,000 adrenaline in oral and maxillofacial surgery for longer duration of surgeries. © The Association of Oral and Maxillofacial Surgeons of India 2020.

Entities:  

Keywords:  Impacted mandibular third molar; Inferior alveolar nerve block; Lignocaine hydrochloride; Ropivacaine

Year:  2020        PMID: 33927491      PMCID: PMC8041965          DOI: 10.1007/s12663-020-01428-6

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  9 in total

Review 1.  Long-acting local anesthetics in dentistry.

Authors:  A L Sisk
Journal:  Anesth Prog       Date:  1992

Review 2.  Ropivacaine.

Authors:  J H McClure
Journal:  Br J Anaesth       Date:  1996-02       Impact factor: 9.166

3.  Ropivacaine: a new local anaesthetic agent in maxillofacial surgery.

Authors:  A Budharapu; R Sinha; U K Uppada; A V S S Subramanya Kumar
Journal:  Br J Oral Maxillofac Surg       Date:  2015-03-24       Impact factor: 1.651

4.  An experimental basis for revising the graphic rating scale for pain.

Authors:  M W Heft; S R Parker
Journal:  Pain       Date:  1984-06       Impact factor: 6.961

Review 5.  Ropivacaine: a pharmacological review.

Authors:  Tom G Hansen
Journal:  Expert Rev Neurother       Date:  2004-09       Impact factor: 4.618

6.  The efficacy of ropivacaine as a dental local anaesthetic.

Authors:  Susanna Axelsson; Göran Isacsson
Journal:  Swed Dent J       Date:  2004

7.  Efficacy and safety of 1% ropivacaine for postoperative analgesia after lower third molar surgery: a prospective, randomized, double-blinded clinical study.

Authors:  Božidar Brković; Miroslav Andrić; Dejan Ćalasan; Marija Milić; Jelena Stepić; Milan Vučetić; Denis Brajković; Ljubomir Todorović
Journal:  Clin Oral Investig       Date:  2016-04-25       Impact factor: 3.573

8.  Comparison of efficacy of 0.75% ropivacaine and 2% lidocaine with 1:200,000 adrenaline in pain control in extraction of mandibular posterior teeth: A double-blind study.

Authors:  Rishab Ranjan; S N Santhosh Kumar; Manju Singh
Journal:  Indian J Dent Res       Date:  2018 Sep-Oct

9.  Comparative evaluation of hemodynamic, vasoconstrictive, and SpO2 variability during different stages of periodontal surgery performed using 0.5% ropivacaine or 2% lignocaine HCl (1:80,000 adrenaline) local anesthesia: A randomized, double-blind, split-mouth pilot study.

Authors:  Ashank Mishra; Zohra Lalani; Butchibabu Kalakonda; Preeti Krishnan; Ruchi Pandey; Krishnajaneya Reddy
Journal:  J Indian Soc Periodontol       Date:  2018 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.